Urological cancer patients receiving treatment during COVID-19: a single-centre perspective

BACKGROUND: Active cancer, immunosuppressive treatments and immunotherapies have been reported to increase cancer patients’ risk of developing severe COVID-19 infection. For patients and clinicians, treatment risk must be weighed against disease progression. METHODS: This retrospective case series s...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Sophie Therese, El Badri, Salma, Hussain, Syed Anwer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869760/
https://www.ncbi.nlm.nih.gov/pubmed/33558714
http://dx.doi.org/10.1038/s41416-021-01263-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869760/
https://www.ncbi.nlm.nih.gov/pubmed/33558714
http://dx.doi.org/10.1038/s41416-021-01263-7

Ejemplares similares